drugset / Trial / NCT00424151
Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy
Phase 1/2
Completed
12 enrolled
Silkiss, Rona Z., M.D., FACS
Coleman, Morton M.D. · collabLauer, Simeon, M.D. · collabReier, Alice M.D. · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study is designed to treat patients with Graves' disease with Rituximab in an attempt to prevent or reverse the physically deforming and debilitating consequences of this disease.
Timeline
- Start
- 2006-12
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rituximab | Monoclonal antibody | — | — |